Japanese health minister Norihisa Tamura said he hopes that Pfizer's COVID-19 vaccine will be approved by mid-February under an accelerated process, as reported in The Japan Times.
Tamura indicated that data from overseas has already been examined, while information from Pfizer's trials in Japan is set to arrive before the end of this month.
Japan's government has signed a contract for 120 million doses of Pfizer's vaccine, which it is developing with BioNTech.
Meanwhile, Tamura said that clinical studies of Moderna's coronavirus vaccine will begin in Japan in late February, with second doses to be completed in early March.
To read more NewsPoints articles, click here.